Examples of using Left ventricular dysfunction in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
Fig 3: Left ventricular dysfunction in the SHHF rat.
Table 5 Dose modifications for left ventricular dysfunction.
Left ventricular dysfunction† including congestive heart failure.
AF has been shown to cause or aggravate left ventricular dysfunction.
Usual levitra levitra order dose for left ventricular dysfunction: initial dose: 10 rph deliberately once a ramelteon in teeth frantically on diuretics.
This will prevent the development of heart failure and left ventricular dysfunction.
Rare: bradycardia, cardiac arrest, left ventricular dysfunction, congestive heart failure, atrioventricular block2.
The problem of patients with high blood pressure is left ventricular dysfunction, an increase in the ventricle from excessive pressure(blood pressure) on it.
This is typical for patients with severe renal insufficiency, hyponatremia, left ventricular dysfunction.
Chronic heart failure complicated by left ventricular dysfunction- as part of a complex of drugs;
Patients treated with trastuzumabemtansine are at increased risk of developing left ventricular dysfunction.
Caution should beexercised in patients with a history of cardiac failure, left ventricular dysfunction, or hypertension and in patients with pre-existing oedema from any other reason.
No specific study has been performed in patients with pulmonary hypertension and concomitant left ventricular dysfunction.
Caution should beexercised in patients with a history of cardiac failure, left ventricular dysfunction, or hypertension and in patients with pre-existing oedema.
It is unknown whether patients with these concomitant conditions maybe at a higher risk of developing sunitinib-related left ventricular dysfunction.
Caution is needed in patients with asymptomatic left ventricular dysfunction, as well as in heart failure patients with NYHA functional classification II due to a limited number of patients studied.
Myocardial ischemia, acute coronary syndrome, cardiac discomfort, ischemic cardiomyopathy, arteriospasm coronary, left ventricular dysfunction, atrial flutter.
In a 36-week study involving 820 patients with ischaemic left ventricular dysfunction, no changes in ventricular remodelling as assessed by left ventricular end systolic volume were detected with aliskiren compared to placebo on top of background therapy.
Other important serious adverse reactions identified in STStrials included venous thromboembolic events, left ventricular dysfunction and pneumothorax.
In a 36-week study involving 820 patients with ischaemic left ventricular dysfunction, no changes in ventricular remodelling as assessed by left ventricular end systolic volume were detected with aliskiren compared to placebo on top of background therapy.
Doxazosin has shown to be free of metabolic adverse effects and is suitable for treatment of patients with coexistent asthma,diabetes, left ventricular dysfunction or gout.
The ANDROMEDA study was conducted in 627 patients with left ventricular dysfunction, hospitalised with new or worsening heart failure and who had had at least one episode of shortness of breath on minimal exertion or at rest(NYHA class III or IV) or paroxysmal nocturnal dyspnoea within the month before admission.
Doxazosin has shown to be free of metabolic adverse effects and is suitable for treatment of patients with coexistent asthma,diabetes, left ventricular dysfunction or gout.
Patients with left ventricular dysfunction, New York Heart Association Class II, III, or IV heart failure, acute coronary syndrome within the past 6 months, clinically significant uncontrolled arrhythmias, and uncontrolled hypertension were excluded from clinical trials; safety of use in this population is therefore unknown.
SHHF animals demonstrate significantly increased left ventricular end-diastolic pressures(LVEDP, mmHg),indicating left ventricular dysfunction in comparison to the normotensive Wistar-Kyoto rat WKY.
In study BO16348, after a median follow-up of 8 years the incidence of severe CHF(NYHA Class III& IV) in the Herceptin 1 year treatment arm was 0.8%,and the rate of mild symptomatic and asymptomatic left ventricular dysfunction was 4.6.
These were reported as adverse events less frequently by investigators than as indicated by laboratory value tables. g Cardiac dysfunction events-includes Left ventricular dysfunction, Cardiac failure and Restrictive cardiomyopathy h Frequency is based on adverse events reported by investigators.
This includes patients with a family history of QT abnormality, concomitant medicinal products that prolong the QT interval, andpatients with left ventricular hypertrophy(LVH) and/or left ventricular dysfunction LVD.
The following terms have been combined: a Abdominal pain, abdominal pain upper and abdominal pain lower b Oedema, oedema peripheral, eye oedema, localised oedema and face oedema c Dysgeusia, ageusia and hypogeusia d White cell count decreased, neutrophil count decreased and leukocyte count decreased e Decreased appetite andanorexia f Cardiac dysfunction, left ventricular dysfunction, cardiac failure and restrictive cardiomyopathy g Venous thromboembolic event, deep vein thrombosis, pulmonary embolism and thrombosis.